Apollo Hospitals Enterprise Limited has informed the Exchange regarding 'Re-appointment of executive directors'.
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board on May 30, 2025 approved audited FY25 results showing strong growth. Standalone revenue rose to Rs 8,202 crore with profit after tax jumping 28% to Rs 1,296 crore (EPS of Rs 90.15). On a consolidated basis, revenue reached Rs 21,794 crore and PAT surged 61% to Rs 1,505 crore. A total dividend of Rs 19 per share (380%) for FY25 has been recommended, with a final dividend of Rs 10/share subject to shareholder approval at the AGM on August 29, 2025. The board also re-appointed three Reddy family executive directors (Preetha, Suneeta, and Sangita Reddy) for another five-year term and approved acquisition of a 200-bed hospital for Rs 285 crore. Credit ratings reaffirmed at AA+ stable by both CRISIL and India Ratings.
Strong double-digit profit growth, a healthy 380% total dividend payout, and continued promoter-led leadership are positive signals for shareholders. The hospital acquisition signals ongoing capacity expansion in the core healthcare business.